Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients–A Single-Center Experience

Vaccination against SARS-CoV-2 infection is currently approved and shows favorable outcomes, but little known about antibody responses in solid organ transplant recipients, since these patients are known to have an impaired immune response upon vaccination and have not been included in admission stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashidi-Alavijeh, Jassin, Frey, Alexandra, Passenberg, Moritz, Korth, Johannes, Zmudzinski, Jaqueline, Anastasiou, Olympia E., Saner, Fuat H., Jahn, Michael, Lange, Christian M., Willuweit, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310292/
https://www.ncbi.nlm.nih.gov/pubmed/34358154
http://dx.doi.org/10.3390/vaccines9070738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310292/
https://www.ncbi.nlm.nih.gov/pubmed/34358154
http://dx.doi.org/10.3390/vaccines9070738

Ejemplares similares